Autolus Therapeutics Ltd reported $266.14M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 206K Dec/2025
Autolus Therapeutics Ltd USD 266.14M 1.88K Sep/2025
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Silence Therapeutics USD 141.7M 0 Dec/2025